FDA Concludes that Existing Regulatory Frameworks for Foods and Supplements are Not Appropriate for Cannabidiol, Will Work with Congress on a New Way Forward

DISTRICT OF COLUMBIA: Given the growing cannabidiol (CBD) products market, the U.S. Food and Drug Administration convened a high-level internal working group to explore potential regulatory pathways for CBD products. Today we are announcing that after careful review, the FDA has concluded that a new regulatory pathway for CBD is needed that balances individuals’ desire Read the full article...
http://dlvr.it/SkCS7Q

Comments

Popular posts from this blog

Hempy 2014!

Coming Out of the Pot Closet

PureTech Provides End of Year Report on Key Progress